AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study
Authors: Jagasia, MH Langer, CJ Johnson, DH Yunus, F Rodgers, JS Schlabach, LL Cohen, AG Shyr, Y Carbone, DP DeVore, RF
Citation: Mh. Jagasia et al., Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study, CLIN CANC R, 7(1), 2001, pp. 68-73
Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients
Authors: Nikitina, EY Clark, JI van Beynen, J Chada, S Virmani, AK Carbone, DP Gabrilovich, DI
Citation: Ey. Nikitina et al., Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients, CLIN CANC R, 7(1), 2001, pp. 127-135
Regulation of mast cell survival by IgE
Authors: Asai, K Kitaura, J Kawakami, Y Yamagata, N Tsai, M Carbone, DP Liu, FT Galli, SJ Kawakami, T
Citation: K. Asai et al., Regulation of mast cell survival by IgE, IMMUNITY, 14(6), 2001, pp. 791-800
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma ofthe head and neck
Authors: Rosenthal, DI Lee, JH Sinard, R Yardley, DA Machtay, M Rosen, DM Egorin, MJ Weber, RS Weinstein, GS Chalian, AA Miller, LK Frenkel, EP Carbone, DP
Citation: Di. Rosenthal et al., Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma ofthe head and neck, J CL ONCOL, 19(5), 2001, pp. 1363-1373
VEGF as a Mediator of tumor-associated immunodeficiency
Authors: Ohm, JE Carbone, DP
Citation: Je. Ohm et Dp. Carbone, VEGF as a Mediator of tumor-associated immunodeficiency, IMMUNOL RES, 23(2-3), 2001, pp. 263-272
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
Authors: Almand, B Clark, JI Nikitina, E van Beynen, J English, NR Knight, SC Carbone, DP Gabrilovich, DI
Citation: B. Almand et al., Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer, J IMMUNOL, 166(1), 2001, pp. 678-689
Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer
Authors: Adachi, Y Itoh, F Yamamoto, H Arimura, Y Kikkawa-Okabe, Y Miyazaki, K Carbone, DP Imai, K
Citation: Y. Adachi et al., Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer, INT J CANC, 95(4), 2001, pp. 216-222
Vascular endothelial growth factor effects on nuclear factor-kappa B activation in hematopoietic progenitor cells
Authors: Dikov, MM Oyama, T Cheng, PY Takahashi, T Takahashi, K Sepetavec, T Edwards, B Adachi, Y Nadaf, S Daniel, T Gabrilovich, DI Carbone, DP
Citation: Mm. Dikov et al., Vascular endothelial growth factor effects on nuclear factor-kappa B activation in hematopoietic progenitor cells, CANCER RES, 61(5), 2001, pp. 2015-2021
Chromosome 19 translocation, overexpression of Notch3, and human lung cancer
Authors: Dang, TP Gazdar, AF Virmani, AK Sepetavec, T Hande, KR Minna, JD Roberts, JR Carbone, DP
Citation: Tp. Dang et al., Chromosome 19 translocation, overexpression of Notch3, and human lung cancer, J NAT CANC, 92(16), 2000, pp. 1355-1357
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
Authors: Terabe, M Matsui, S Noben-Trauth, N Chen, HJ Watson, C Donaldson, DD Carbone, DP Paul, WE Berzofsky, JA
Citation: M. Terabe et al., NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway, NAT IMMUNOL, 1(6), 2000, pp. 515-520
Clinical significance of defective dendritic cell differentiation in cancer
Authors: Almand, B Resser, JR Lindman, B Nadaf, S Clark, JI Kwon, ED Carbone, DP Gabrilovich, DI
Citation: B. Almand et al., Clinical significance of defective dendritic cell differentiation in cancer, CLIN CANC R, 6(5), 2000, pp. 1755-1766
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin
Authors: Rosenthal, DI Becerra, CR Toto, RD Carbone, DP Frenkel, EP
Citation: Di. Rosenthal et al., Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin, AM J CL ONC, 23(6), 2000, pp. 593-598
Biological considerations in lung cancer
Authors: Almand, B Carbone, DP
Citation: B. Almand et Dp. Carbone, Biological considerations in lung cancer, CANC TREAT, 2000, pp. 1-30
Mutant oncogene and tumor suppressor gene products and fusion proteins created by chromosomal translocations as targets for cancer vaccines
Authors: Maher, VE Worley, BS Contois, D Smith, MC Kelley, MJ Stipanov, M Khleif, SN Goletz, T van den Broeke, L Mackall, C Helman, LJ Carbone, DP Berzofsky, JA
Citation: Ve. Maher et al., Mutant oncogene and tumor suppressor gene products and fusion proteins created by chromosomal translocations as targets for cancer vaccines, MED INTEL U, 24, 2000, pp. 17-39
Genetic subunit vaccines - A novel approach for genetic immunization
Authors: Ciernik, IF Carbone, DP
Citation: If. Ciernik et Dp. Carbone, Genetic subunit vaccines - A novel approach for genetic immunization, METH MOL M, 29, 2000, pp. 345-353
A phase I single-dose trial of Gadolinium Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging
Authors: Rosenthal, DI Nurenberg, P Becerra, CR Frenkel, EP Carbone, DP Lum, BL Miller, R Engel, J Young, S Miles, D Renschler, MF
Citation: Di. Rosenthal et al., A phase I single-dose trial of Gadolinium Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging, CLIN CANC R, 5(4), 1999, pp. 739-745
Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function
Authors: Gabrilovich, DI Ishida, T Nadaf, S Ohm, JE Carbone, DP
Citation: Di. Gabrilovich et al., Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function, CLIN CANC R, 5(10), 1999, pp. 2963-2970
Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers
Authors: Dowell, JE Sinard, R Yardley, DA Aviles, V Machtay, M Weber, RS Weinstein, GS Chalian, AA Carbone, DP Rosenthal, DI
Citation: Je. Dowell et al., Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers, SEM RAD ONC, 9(2), 1999, pp. 97-101
Molecular modalities in the treatment of lung cancer
Authors: Carbone, DP
Citation: Dp. Carbone, Molecular modalities in the treatment of lung cancer, ONCOLOGY-NY, 13(10), 1999, pp. 142-147
Increased dose-intensity in small-cell lung cancer: A failed strategy?
Authors: Johnson, DH Carbone, DP
Citation: Dh. Johnson et Dp. Carbone, Increased dose-intensity in small-cell lung cancer: A failed strategy?, J CL ONCOL, 17(8), 1999, pp. 2297-2299
Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope
Authors: Ciernik, IF Romero, P Berzofsky, JA Carbone, DP
Citation: If. Ciernik et al., Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope, INT J RAD O, 45(3), 1999, pp. 735-741
Radiopotentiation by the oral platinum agent, JM216: Role of repair inhibition
Authors: Amorino, GP Freeman, ML Carbone, DP Lebwohl, DE Choy, H
Citation: Gp. Amorino et al., Radiopotentiation by the oral platinum agent, JM216: Role of repair inhibition, INT J RAD O, 44(2), 1999, pp. 399-405
Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo
Authors: Ohm, JE Shurin, MR Esche, C Lotze, MT Carbone, DP Gabrilovich, DI
Citation: Je. Ohm et al., Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo, J IMMUNOL, 163(6), 1999, pp. 3260-3268
A model for CD8(+) CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL
Authors: Matsui, S Ahlers, JD Vortmeyer, AO Terabe, M Tsukui, T Carbone, DP Liotta, LA Berzofsky, JA
Citation: S. Matsui et al., A model for CD8(+) CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL, J IMMUNOL, 163(1), 1999, pp. 184-193
Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses
Authors: Ishida, T Chada, S Stipanov, M Nadaf, S Ciernik, FI Gabrilovich, DI Carbone, DP
Citation: T. Ishida et al., Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses, CLIN EXP IM, 117(2), 1999, pp. 244-251
Risultati: 1-25 | 26-27